stocks logo

MRVI Financial Analysis

Maravai LifeSciences Holdings Inc
$
1.940
-0.160(-7.620%)

MRVI Financial Analysis

FY2024Q4FY2024Q3FY2024Q2FY2024Q1FY2023Q4FY2023Q3FY2023Q2FY2023Q1FY2022Q4FY2022Q3FY2022Q2FY2022Q1FY2021Q4FY2021Q3FY2021Q2FY2021Q1FY2020Q4FY2020Q3
Valuation ratios
PE
0.00
0.00
-100.00%
0.00
-100.00%
0.00
-100.00%
0.00
-100.00%
51.22
261.98%
21.30
43.24%
12.00
-37.98%
8.57
-68.08%
14.15
-65.74%
14.87
19.35
26.85
-74.70%
41.30
0.00
0.00
106.13
0.00
EV/EBITDA
0.00
-100.00%
278.34
1295.89%
196.74
1438.23%
337.14
3913.57%
65.10
923.58%
19.94
92.29%
12.79
14.61%
8.40
-41.54%
6.36
-67.08%
10.37
-63.89%
11.16
14.37
19.32
-68.84%
28.72
0.00
0.00
62.00
0.00
EV/FCF
0.00
-100.00%
0.00
-100.00%
0.00
-100.00%
0.00
-100.00%
32.95
337.58%
17.57
24.35%
12.96
-17.66%
8.73
-55.44%
7.53
-75.80%
14.13
-60.16%
15.74
19.59
31.12
-53.50%
35.47
0.00
0.00
66.92
0.00
P/FCF
0.00
-100.00%
0.00
-100.00%
0.00
-100.00%
0.00
-100.00%
14.24
166.67%
8.10
-32.50%
6.11
-59.80%
5.22
-67.96%
5.34
-75.12%
12.00
-51.16%
15.20
16.29
21.46
24.57
0.00
0.00
0.00
0.00
PS
2.90
-3.01%
4.07
29.62%
3.42
13.62%
4.18
31.86%
2.99
-4.78%
3.14
-50.47%
3.01
-61.99%
3.17
-63.56%
3.14
-66.95%
6.34
-52.29%
7.92
8.70
9.50
13.29
0.00
0.00
0.00
0.00
PB
2.38
14.42%
3.41
34.25%
2.32
-26.35%
2.80
-20.90%
2.08
-39.88%
2.54
-61.92%
3.15
-61.49%
3.54
-70.79%
3.46
-80.18%
6.67
-68.70%
8.18
-66.76%
12.12
-60.38%
17.46
-43.00%
21.31
24.61
30.59
30.63
0.00
Dividend Yield- %
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
FCF Yield- %
-3.15
-144.87%
-1.04
-108.42%
-1.78
-110.87%
-2.68
-113.99%
7.02
-62.54%
12.35
48.08%
16.37
148.78%
19.16
212.05%
18.74
302.15%
8.34
104.91%
6.58
6.14
4.66
4.07
0.00
0.00
0.00
0.00
PEG
0.00
0.00
-100.00%
0.00
-100.00%
0.00
-100.00%
0.00
-100.00%
-0.57
-311.11%
-0.31
-0.33
1.23
2360.00%
0.27
237.50%
0.00
0.00
0.05
-58.33%
0.08
0.00
0.00
0.12
0.00
Profitability Ratios
Gross Profit Margin - %
33.62
-36.14%
43.52
-3.57%
47.86
28.62%
40.27
-29.83%
52.65
-28.84%
45.13
-43.62%
37.21
-55.99%
57.39
-31.36%
73.99
-10.00%
80.04
-5.02%
84.55
2.31%
83.61
6.08%
82.21
7.87%
84.27
20.89%
82.64
78.82
76.21
51.15%
69.71
28.47%
EBITDA Margin - %
-21.17
-240.76%
-0.65
-122.26%
4.31
-2152.38%
-8.55
-138.22%
15.04
-74.66%
2.92
-95.63%
-0.21
-100.28%
22.37
-69.76%
59.36
-10.71%
66.83
-8.86%
75.88
3.77%
73.97
11.42%
66.48
75.92%
73.33
52.01%
73.12
66.39
37.79
69.84%
48.24
27.99%
Operating Margin - %
-43.09
-10120.93%
-18.96
40.55%
-12.61
-11.88%
-26.71
-339.98%
0.43
-99.22%
-13.49
-121.56%
-14.31
-119.74%
11.13
-84.31%
55.35
-16.74%
62.57
-10.87%
72.51
3.50%
70.95
14.18%
66.48
109.25%
70.20
87.20%
70.06
62.14
31.77
736.05%
37.50
75.15%
FCF Margin - %
-9.14
-143.52%
-4.23
-110.90%
-6.07
-112.32%
-11.19
-118.40%
21.00
-64.26%
38.81
-26.51%
49.28
-5.41%
60.82
13.85%
58.76
32.76%
52.81
-2.37%
52.10
53.42
44.26
7.04%
54.09
97.63%
0.00
0.00
41.35
749.08%
27.37
Net Margin - %
-82.43
-44.43%
-269.87
1094.64%
-19.74
13.91%
-35.34
1966.67%
-148.34
-447.32%
-22.59
-143.36%
-17.33
-126.84%
-1.71
-102.84%
42.71
-22.71%
52.10
-19.27%
64.57
4.55%
60.12
18.07%
55.26
275.66%
64.54
86.32%
61.76
50.92
14.71
-197.03%
34.64
14960.87%
Financial Health Ratios
Current Ratio
7.53
-5.87%
10.74
19.87%
10.00
7.18%
11.32
84.67%
8.00
3.90%
8.96
24.10%
9.33
38.22%
6.13
-14.15%
7.70
-2.41%
7.22
20.13%
6.75
72.63%
7.14
176.74%
7.89
210.63%
6.01
624.10%
3.91
2.58
2.54
0.83
Quick Ratio
6.65
-10.26%
9.94
19.33%
9.28
6.67%
10.47
84.01%
7.41
1.37%
8.33
24.70%
8.70
40.10%
5.69
-13.13%
7.31
-0.41%
6.68
21.01%
6.21
71.55%
6.55
186.03%
7.34
221.93%
5.52
645.95%
3.62
2.29
2.28
0.74
Debt to Equity
56.80
-19.41%
90.32
44.51%
71.45
14.82%
71.49
18.48%
70.48
20.97%
62.50
-0.41%
62.23
-8.99%
60.34
-25.50%
58.26
-40.12%
62.76
-51.59%
68.38
-61.34%
80.99
-71.18%
97.29
-74.52%
129.64
-88.57%
176.89
281.05
381.77
1.13K
Interest Coverage Ratio
-2.16
-10900.00%
-0.91
18.18%
-0.78
-44.29%
-1.58
-313.51%
0.02
-99.82%
-0.77
-102.02%
-1.40
-103.53%
0.74
-98.86%
11.13
-67.51%
38.16
103.96%
39.69
98.95%
65.06
458.45%
34.26
865.07%
18.71
488.36%
19.95
11.65
3.55
1872.22%
3.18
208.74%
Efficiency Ratios
ROE
-39.04
57.74%
-51.98
-1182.92%
-27.59
-278.58%
-28.11
-182.90%
-24.75
-148.37%
4.80
-91.88%
15.45
-79.73%
33.91
-62.82%
51.17
-43.22%
59.13
-33.06%
76.22
91.20
90.12
88.33
0.00
0.00
0.00
0.00
ROIC
0.00
-100.00%
0.00
0.00
0.00
-9.31
-149.00%
0.00
-100.00%
0.00
-100.00%
0.00
-100.00%
19.00
-17.14%
21.03
-12.81%
24.00
25.03
22.93
24.12
0.00
0.00
0.00
0.00
ROA
-20.81
183.51%
-18.23
-798.47%
-8.74
-211.48%
-8.49
-154.04%
-7.34
-131.42%
2.61
-89.80%
7.84
-73.73%
15.71
-50.68%
23.36
-20.63%
25.60
-5.50%
29.84
31.85
29.43
27.09
0.00
0.00
0.00
0.00
Average Inventory Days
123.09
5.82%
122.65
0.25%
119.24
2.05%
124.86
4.44%
116.32
13.39%
122.34
-12.77%
116.85
-11.88%
119.55
-1.08%
102.58
-7.15%
140.25
15.49%
132.61
120.86
110.48
121.44
0.00
0.00
0.00
0.00
Inventory Turnover
2.97
-5.71%
2.98
-0.33%
3.07
-1.92%
2.93
-4.25%
3.15
-11.76%
2.99
14.56%
3.13
13.41%
3.06
0.99%
3.57
7.85%
2.61
-13.29%
2.76
3.03
3.31
3.01
0.00
0.00
0.00
0.00
Average Receivables Collection Days
66.54
-48.13%
51.60
-34.80%
58.12
-3.04%
64.37
42.44%
128.27
134.15%
79.14
97.90%
59.94
41.87%
45.19
-9.07%
54.78
41.81%
39.99
4.41%
42.25
49.70
38.63
38.30
0.00
0.00
0.00
0.00
Accounts Receivable Turnover
5.50
92.98%
7.09
53.46%
6.30
3.11%
5.69
-29.75%
2.85
-57.34%
4.62
-49.51%
6.11
-29.45%
8.10
10.05%
6.68
-29.46%
9.15
-4.29%
8.66
7.36
9.47
9.56
0.00
0.00
0.00
0.00
Payables Turnover
13.30
-25.24%
15.70
-11.20%
15.46
37.42%
23.58
9.98%
17.79
-25.53%
17.68
4.93%
11.25
32.20%
21.44
45.06%
23.89
38.73%
16.85
12.78%
8.51
14.78
17.22
14.94
0.00
0.00
0.00
0.00
Sales per Employee
424.89K
-7.36%
443.07K
-32.93%
449.33K
-50.02%
449.34K
-63.38%
458.64K
-71.95%
660.66K
-61.38%
899.03K
-49.20%
1.23M
-32.85%
1.64M
-9.98%
1.71M
1.77M
1.83M
1.82M
0.00
0.00
0.00
0.00
0.00
Net Profit per Employee
-425.61K
93.77%
-516.97K
-656.07%
-261.70K
-191.10%
-261.81K
-144.72%
-219.64K
-124.17%
92.97K
-90.71%
287.26K
-73.46%
585.39K
-46.94%
908.64K
-14.80%
1.00M
1.08M
1.10M
1.07M
0.00
0.00
0.00
0.00
0.00
R&D % of Revenue
8.09
50.09%
6.66
2.46%
7.20
18.23%
7.84
49.33%
5.39
150.70%
6.50
130.50%
6.09
246.02%
5.25
247.68%
2.15
-42.67%
2.82
196.84%
1.76
97.75%
1.51
3.42%
3.75
1775.00%
0.95
-75.52%
0.89
1.46
0.20
-92.65%
3.88
57.09%
Dividend Payout Ratio - %
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Growth Ratio
Total Revenue, YoY % Chg
-23.92
-62.50%
-2.49
-96.17%
6.51
-109.09%
-18.79
-72.22%
-63.78
513.86%
-65.04
883.96%
-71.61
-724.87%
-67.65
-204.35%
-10.39
-107.86%
-6.61
11.46
64.83
132.27
-23.77%
0.00
0.00
0.00
173.51
0.00
EBITDA, YoY % Chg
-207.08
128.01%
-121.70
23.59%
2.25K
-2351.94%
-131.03
45.23%
-90.82
354.33%
-98.47
561.32%
-100.08
-738.67%
-90.22
-207.85%
-19.99
-106.48%
-14.89
15.67
83.65
308.57
-15.35%
0.00
0.00
0.00
364.51
0.00
EPS, YoY % Chg
77.01
-132.03%
-1.33K
1060.29%
-12.58
-88.49%
-17.80K
17678.30%
-240.43
-801.58%
-114.49
380.44%
-109.28
-594.03%
-100.10
-191.23%
34.27
-94.75%
-23.83
22.12
109.72
652.82
99.16%
0.00
0.00
0.00
327.78
0.00

MRVI FAQs

What is MRVI's PE Ratio in 2025/4/4?

MRVI's PE ratio in April 4, 2025 is -1.85. This indicates the price investors are willing to pay for $1 of earnings.

What is MRVI's PS Ratio in 2025/4/4?

What is MRVI's Dividend Yield in 2024/Q4?

What is MRVI's Gross Margin in 2024/Q4?

Free Financial AI Agent for Investment

Ask any investment related question and get answer instantly

Is MRVI earnings result positive or negative?How should I trade on MRVI earnings?